Right/Left Discrimination Training on Fibromyalgia Patients
NCT ID: NCT05915598
Last Updated: 2023-06-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
64 participants
INTERVENTIONAL
2023-06-25
2024-08-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigating the Role of Central Pain Hypersensitivity in Skeletal Muscle Neural Drive
NCT07281651
Effect of Neuromodulation on Pain Biomarkers and Functional Outcome in Patients With Fibromyalgia Syndrome
NCT06539793
Audio Vestibular Assessment in Patients with Fibromyalgia
NCT06579560
Pain Neuroscience Education in Patients with Fibromyalgia
NCT04050839
Consensus-Based vs. Standardized Physiotherapy for Fibromyalgia
NCT06913868
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
Right/left discrimination training: The training program will consist of tasks such as identifying the laterality of images (e.g., hands, feet, faces) and sounds (e.g., spatially localized sounds). The tasks will be designed with increasing levels of difficulty to challenge participants and promote skill development.
Training schedule: Participants will be instructed to engage in the right/left discrimination training for 20 minutes per day, 5 days per week, over a six-week period. They will be encouraged to complete the training sessions at consistent times to support habit formation.
Monitoring and feedback: The research team will remotely monitor participants' progress and provide personalized feedback on a weekly basis. This will include reviewing performance metrics within the app, discussing any challenges or barriers to adherence, and offering guidance to support continued engagement in the training program.
Right/left discrimination training
Participants will use recognize app by Neuro-orthopedic institute (NOI) for daily right/left discrimination training.
The training will include visual and auditory stimuli, with tasks such as identifying the laterality of images and sounds.
Participants will engage in training for 20 minutes per day, 5 days per week, over a six-week period.
Weekly monitoring and feedback will be provided by the research team
Control group
Usual care: Participants will continue their usual care management for fibromyalgia, including any prescribed medications and physician consultations. No specific right/left discrimination training will be provided to the control group.
usual care
Usual care: Participants will continue their usual care management for fibromyalgia, including any prescribed medications and physician consultations. No specific right/left discrimination training will be provided to the control group.
Follow-up assessments: Participants in the control group will undergo the same follow-up assessments as the intervention group to evaluate changes in pain perception, functional disability, and cognitive function.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Right/left discrimination training
Participants will use recognize app by Neuro-orthopedic institute (NOI) for daily right/left discrimination training.
The training will include visual and auditory stimuli, with tasks such as identifying the laterality of images and sounds.
Participants will engage in training for 20 minutes per day, 5 days per week, over a six-week period.
Weekly monitoring and feedback will be provided by the research team
usual care
Usual care: Participants will continue their usual care management for fibromyalgia, including any prescribed medications and physician consultations. No specific right/left discrimination training will be provided to the control group.
Follow-up assessments: Participants in the control group will undergo the same follow-up assessments as the intervention group to evaluate changes in pain perception, functional disability, and cognitive function.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adults between 35 - 55 years old
* Both sexes
* Stable medication use for at least one month prior to enrollment
Exclusion Criteria
* Current involvement in another pain management program or study
35 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ahram Canadian University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohamed Magdy ElMeligie
Lecturer of Physical Therapy and Director of Electromyography Lab
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amal Fawzy, Ph.d
Role: STUDY_DIRECTOR
Faculty of Physical Therapy, Ahram Canadian University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Outpatient clinic of faculty of physical therapy, Ahram Canadian University
Al Ḩayy Ath Thāmin, Giza Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
012/0059000012
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.